Fuchs Endothelial Corneal Dystrophy is a bilateral
(affecting both eyes) disease characterized by the premature degeneration of corneal endothelial cells

In patients with FECD, the telomeres of corneal endothelial cells are even shorter than those in individuals without the disease
Revolutionizing Eye Care

Understanding Fuchs Endothelial Corneal Dystrophy

The Role of the Cornea and Corneal Endothelial Cells

The cornea ensures clear vision, relying on corneal endothelial cells (CECs) to regulate hydration. As CECs cannot regenerate, their health is crucial for maintaining corneal clarity.

Understanding Fuchs Endothelial Corneal Dystrophy

FECD is a disease causing premature corneal endothelial cell degeneration. This disrupts corneal hydration, leading to swelling and impaired vision.

Understanding Telomeres

Telomeres are protective caps at the ends of chromosomes, preventing them from fraying.
Like plastic tips on shoelaces, they preserve genetic material and prevent cells from aging prematurely.
landing product
About TelomEye

Leading the Way in Vision Restoration

TelomEye is a Toronto-based biotechnology company revolutionizing the field of ophthalmology. Since 2021, we have been committed to developing innovative, non-invasive treatments for vision restoration. Our groundbreaking product, TAED017, leverages Nobel Prize-winning science to address unmet needs in eye care.

With a dedicated team of scientists and medical professionals, we aim to provide hope and solutions for millions suffering from corneal diseases like Fuchs’ Dystrophy. At TelomEye, we believe in transforming lives by preserving and enhancing vision.